Finance

Lists
185750:KRX
Chong Kun Dang Pharmaceutical Corp
67 700,00 KRW
+1,96%
(+1 300,00) 1D
19 ოქტ, 15:30:01 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 185750...
Open
66 600 KRW
High
68 000 KRW
Low
65 500 KRW
Mkt. cap
934,45 მლრ.
Avg. vol.
20,59 ათ.
Volume
13,59 ათ.
Dividend
0,74%
Quarterly dividend
125 KRW
Ex-dividend date
29 დეკ. 2025
P/E ratio
11,20
52-wk high
98 100 KRW
52-wk low
63 000 KRW
EPS
6 047 KRW
Shares outstanding
13,80 მლნ.
No. of employees
2 ათ.
Open
66 600 KRW
High
68 000 KRW
Low
65 500 KRW
Mkt. cap
934,45 მლრ.
Avg. vol.
20,59 ათ.
Volume
13,59 ათ.
Dividend
0,74%
Quarterly dividend
125 KRW
Ex-dividend date
29 დეკ. 2025
P/E ratio
11,20
52-wk high
98 100 KRW
52-wk low
63 000 KRW
EPS
6 047 KRW
Shares outstanding
13,80 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
The Motley Fool
The Motley Fool
·
14 წუთის წინ
Tesla Stock vs. the S&P 500: Which Investment Wins Through 2030?
About Chong Kun Dang Pharmaceutical Corp
CEOიუნგ-ჯუ კიმ
Employees2,17 ათ.
Founded1941
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
429,82 მლრ.
426,78 მლრ.
447,77 მლრ.
478,47 მლრ.
Cost of goods sold
293,70 მლრ.
296,28 მლრ.
323,78 მლრ.
338,01 მლრ.
Cost of revenue
293,70 მლრ.
296,28 მლრ.
323,78 მლრ.
338,01 მლრ.
Research and development expenses
41,01 მლრდ.
35,34 მლრდ.
35,06 მლრდ.
45,96 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,14 მლრდ.
66,74 მლრდ.
68,78 მლრდ.
70,53 მლრდ.
Operating expense
115,13 მლრ.
107,01 მლრ.
109,90 მლრ.
121,85 მლრ.
Total operating expenses
408,83 მლრ.
403,30 მლრ.
433,68 მლრ.
459,85 მლრ.
Operating income
20,99 მლრდ.
23,48 მლრდ.
14,09 მლრდ.
18,61 მლრდ.
Other non operating income
252,87 მლნ.
363,50 მლნ.
362,33 მლნ.
-438,08 მლნ.
EBT including unusual items
20,81 მლრდ.
24,82 მლრდ.
13,70 მლრდ.
17,53 მლრდ.
EBT excluding unusual items
20,90 მლრდ.
23,93 მლრდ.
13,95 მლრდ.
17,14 მლრდ.
Income tax expense
576,67 მლნ.
-1,47 მლრდ.
1,08 მლრდ.
-2,89 მლრდ.
Effective tax rate
2,77%
-5,93%
7,90%
-16,51%
Other operating expenses
2,80 მლრდ.
2,73 მლრდ.
3,80 მლრდ.
2,82 მლრდ.
Net income
20,10 მლრდ.
26,55 მლრდ.
12,82 მლრდ.
19,99 მლრდ.
Net profit margin
4,68%
6,22%
2,86%
4,18%
Earnings per share
-
-
-
-
Interest and investment income
1,25 მლრდ.
1,91 მლრდ.
1,80 მლრდ.
1,95 მლრდ.
Interest expense
-1,19 მლრდ.
-1,81 მლრდ.
-2,28 მლრდ.
-2,64 მლრდ.
Net interest expenses
58,24 მლნ.
97,72 მლნ.
-478,19 მლნ.
-686,60 მლნ.
Depreciation and amortization charges
1,37 მლრდ.
1,33 მლრდ.
1,29 მლრდ.
1,37 მლრდ.
EBITDA
32,20 მლრდ.
34,88 მლრდ.
25,66 მლრდ.
30,21 მლრდ.
Gain or loss from assets sale
-25,05 მლნ.
-515,84 მლნ.
138,15 მლნ.
8,00 ათ.
AI content may include mistakes. Learn more
Google აპები